MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Quality of life measurement in patients with generalized dystonia who underwent deep brain stimulation treatment.

H. Pacheco, V. Gomez, C. Sánchez, L. Núñez (Mexico, Mexico)

Meeting: 2025 International Congress

Keywords: Dystonia: Clinical features, Dystonia: Treatment

Category: Dystonia: Medical Therapy / Surgical Therapy

Objective: To measure the improvement in perceived Quality of Life (QoL) in patients who underwent to DBS placement.

Background: Generalized dystonias are characterized by sustained or intermittent muscle contractions resulting in twisting and abnormal repetitive movements, postures, or both; often initiated or worsened by voluntary action and associated with overflow muscle activation; most forms are idiopathic; however, several have a genetic or acquired background. Dystonias could have a significant impact in the QoL due to limitation of muscular development, disability, pain and emotional impact. Treatment involves drugs, regular botulinum toxin injections and deep brain stimulation (DBS) surgery as a modality for patients with resistant dystonia.

Method: 6 selected patients with generalized dystonia resistant to conservative treatment who underwent DBS surgery and QoL measure with a modified Parkinson’s Disease Questionnaire-8 (PDQ-8), pre and post-surgery.

Results: Demographic information and clinical characteristics of patients are seen on table 1. We performed an evaluation of QoL before (Graphic 1) and after surgery (Graphic 2) and found that majority of patients perceive a subjective improvement in QoL after surgery (27.5%), less than the improvement measured with the PDQ-8 (43%).

Conclusion: Generalized dystonia remains a challenge in diagnosis and treatment. As far as we know, there is no QoL evaluation tool specially designed for this disease, but the PDQ-8 evaluates the QoL related to Parkinson’s Disease and it can be useful in other movement disorders, like generalized dystonias. Evaluation of QoL is important to measure the impact of the disease and try to improve non-motor symptoms of dystonia.

Table 1. Demographic information.

Table 1. Demographic information.

Image 1. PDQ-8 measure before DBS surgery.

Image 1. PDQ-8 measure before DBS surgery.

Image 2. PDQ-8 measure after DBS surgery.

Image 2. PDQ-8 measure after DBS surgery.

References: 1. di Biase, L., Di Santo, A., Caminiti, M. L., Pecoraro, P. M., & Di Lazzaro, V. (2022). Classification of dystonia. Life, 12(2), 206.
2. Woo, K. A., Kim, H. J., Jeon, S. H., Park, H. R., Park, K. W., Lee, S. H., … & Jeon, B. (2022). Long-term outcomes of deep brain stimulation in pantothenate kinase-associated neurodegeneration-related dystonia. Journal of Movement Disorders, 15(3), 241.

To cite this abstract in AMA style:

H. Pacheco, V. Gomez, C. Sánchez, L. Núñez. Quality of life measurement in patients with generalized dystonia who underwent deep brain stimulation treatment. [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/quality-of-life-measurement-in-patients-with-generalized-dystonia-who-underwent-deep-brain-stimulation-treatment/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/quality-of-life-measurement-in-patients-with-generalized-dystonia-who-underwent-deep-brain-stimulation-treatment/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley